1. Home
  2. STVN vs HOMB Comparison

STVN vs HOMB Comparison

Compare STVN & HOMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • HOMB
  • Stock Information
  • Founded
  • STVN 1949
  • HOMB 1998
  • Country
  • STVN Italy
  • HOMB United States
  • Employees
  • STVN N/A
  • HOMB N/A
  • Industry
  • STVN Containers/Packaging
  • HOMB Major Banks
  • Sector
  • STVN Consumer Discretionary
  • HOMB Finance
  • Exchange
  • STVN Nasdaq
  • HOMB Nasdaq
  • Market Cap
  • STVN 5.7B
  • HOMB 5.0B
  • IPO Year
  • STVN 2021
  • HOMB 2006
  • Fundamental
  • Price
  • STVN $21.55
  • HOMB $27.67
  • Analyst Decision
  • STVN Buy
  • HOMB Hold
  • Analyst Count
  • STVN 6
  • HOMB 5
  • Target Price
  • STVN $25.08
  • HOMB $31.00
  • AVG Volume (30 Days)
  • STVN 334.9K
  • HOMB 1.2M
  • Earning Date
  • STVN 05-08-2025
  • HOMB 04-16-2025
  • Dividend Yield
  • STVN 0.27%
  • HOMB 2.83%
  • EPS Growth
  • STVN N/A
  • HOMB 8.29
  • EPS
  • STVN 0.45
  • HOMB 2.09
  • Revenue
  • STVN $1,143,012,735.00
  • HOMB $987,214,000.00
  • Revenue This Year
  • STVN $8.42
  • HOMB $9.80
  • Revenue Next Year
  • STVN $10.36
  • HOMB $1.22
  • P/E Ratio
  • STVN $47.85
  • HOMB $13.19
  • Revenue Growth
  • STVN 1.72
  • HOMB 1.15
  • 52 Week Low
  • STVN $16.56
  • HOMB $22.42
  • 52 Week High
  • STVN $28.77
  • HOMB $32.91
  • Technical
  • Relative Strength Index (RSI)
  • STVN 52.82
  • HOMB 54.67
  • Support Level
  • STVN $21.13
  • HOMB $27.20
  • Resistance Level
  • STVN $22.46
  • HOMB $28.41
  • Average True Range (ATR)
  • STVN 1.25
  • HOMB 1.10
  • MACD
  • STVN 0.07
  • HOMB 0.31
  • Stochastic Oscillator
  • STVN 75.56
  • HOMB 82.30

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About HOMB Home BancShares Inc.

Home BancShares Inc is a bank holding company that operates through its wholly owned community bank subsidiary, Centennial Bank. The bank provides a broad range of commercial and retail banking, as well as related financial services, to a diverse customer base. Its customer base includes businesses, real estate developers and investors, individuals, and municipalities. The company's loan portfolio, while diversified, is typically between half and two thirds in commercial real estate loans. The company's plan emphasizes growth, both through strategic acquisitions and organically within its existing markets. The bank also emphasizes attracting experienced bankers, credit quality and a solid balance sheet. The bank's main source of net revenue is net interest income.

Share on Social Networks: